Home › Pathology › Classification and Pathogenetic Mechanisms of Dystrophies

Classification and Mechanisms of Dystrophies

*Dystrophia*

For medical students2 min readUpdated 2026-10-10

Dystrophy is a pathological process characterized by impaired tissue or cellular nutrition (trophism), leading to structural alterations. As a result, excessive, altered, or entirely atypical substances accumulate within cells or the intercellular matrix. The process can be reversible or culminate in irreversible consequences, namely cell death.

Core ProcessImpairment of cellular and extracellular mechanisms maintaining trophic homeostasis

GeneticsHereditary enzymopathies lead to storage diseases (thesaurismoses)

LocalizationClassified into parenchymal, stromal-vascular (mesenchymal), and mixed types

OutcomeIrreversible dystrophy terminates in coagulative or liquefactive necrosis

What is Trophism and Why Does It Fail?

Trophism ensures proper metabolism and structural organization of tissues, which is necessary for them to perform their specialized functions. It is maintained at two levels:

Cellular: via genetically determined autoregulation and the structural integrity of the cell itself.
Extracellular: via transport systems (blood, lymph) and integrative systems (nervous, endocrine, humoral).

When these mechanisms fail, dystrophy develops. The etiology of the process is extremely diverse. Causes may include hypoxia, toxins (including microbial agents) and drugs, physical and chemical agents, viruses, and nutritional imbalances. Dystrophies frequently develop against the background of nervous and endocrine system disorders, changes in blood or urine composition, and genetic enzyme defects (enzymopathies).

Morphologically, dystrophy manifests in several ways:

Substances accumulate in tissues in quantities exceeding normal levels.
The physicochemical properties of routine compounds are altered.
Usual substances appear in atypical locations.
Entirely novel substances appear that are absent in normal physiology (within cells, in the stroma, intercellular matrix, or vessel walls).

Principles of Classification

The pathological process is systematized according to several key criteria.

By the type of metabolic disturbance:

Protein.
Lipid (fatty).
Carbohydrate.
Mineral.
Fluid (water).
Mixed.

By predominant localization:

Parenchymal (disturbances within cells).
Stromal-vascular / Mesenchymal (disturbances in the extracellular matrix and vessel walls).
Mixed.

By genetic influence:

Hereditary: caused by a genetic enzyme defect. Metabolic products are not degraded, leading to storage diseases (thesaurismoses).
Acquired: associated with secondary enzymopathies, often occurring secondary to impaired substance transport or energy supply.

Additionally, depending on the distribution of the process, systemic ( generalized) and localized dystrophies are distinguished.

Morphogenetic Mechanisms

There are four fundamental pathways by which morphological changes develop in dystrophies:

Infiltration. Excessive penetration of substances into a cell or intercellular matrix with their subsequent accumulation. This occurs either due to an excess of the substance in the incoming fluid or a lack of enzymes for its processing. Examples: protein accumulation in renal tubular epithelium during proteinuria; lipid accumulation in the myocardium during diphtheria (due to disruption of the carnitine shuttle transport); deposition of non-eliminable exogenous particles (e.g., anthracotic carbon pigment).
Decomposition (Phanerosis). Breakdown of complex chemical compounds or cellular ultrastructures leading to the accumulation of breakdown products. Example: fibrinoid changes in connective tissue during rheumatic diseases due to the breakdown of polysaccharide-protein complexes.
Transformation. The chemical conversion of one type of substance into another. Example: conversion of carbohydrates into fats in diabetes mellitus.
Aberrant synthesis (Perverted synthesis). The formation of entirely new, abnormal substances in tissues. Example: synthesis and deposition of amyloid in the intercellular space.

Clinical Course and Outcomes

Morphogenetic mechanisms rarely operate in isolation: they can combine or transition into one another (e.g., infiltration frequently serves as a preceding stage to decomposition). Each specific organ exhibits a typical mechanism of injury determined by its structural and functional characteristics—a phenomenon known as orthology (from Greek orthos — typical).

Morphological types include granular, hyaline-droplet, hydropic, and keratinizing (horny) dystrophies (the mechanism of the latter differing from the others).

If the process becomes irreversible, the cell dies. The type of resulting necrosis (focal or total) depends directly on the preceding pathology:

Hyaline-droplet dystrophy leads to coagulative necrosis.
Hydropic dystrophy culminates in liquefactive necrosis (ballooning degeneration).

Mnemonic

To easily recall the 4 mechanisms of dystrophy development, use the mnemonic IDTI: Infiltration, Decomposition, Transformation, Inverted (aberrant) synthesis.

Frequently asked questions

What types of parenchymal protein dystrophies (dysproteinoses) are distinguished in pathology?

Pathology distinguishes four main morphological types of parenchymal protein dystrophies. These include:

Granular dystrophy — characterized by hyperplasia of cell ultrastructures or cellular swelling.
Hyaline-droplet dystrophy — manifested by the formation of large eosinophilic droplets in the cytoplasm.
Hydropic dystrophy — accompanied by fluid accumulation and vacuole formation in the cytoplasm.
Keratinizing (horny) dystrophy — whose development mechanism differs from the preceding types.

What sequential stages are distinguished in the development of stromal-vascular protein dystrophies?

The development of stromal-vascular protein dystrophies involves three sequential stages of connective tissue disorganization. The dynamics of the process include:

Mucoid swelling — the initial stage characterized by the accumulation of glycosaminoglycans in the ground substance.
Fibrinoid swelling — the subsequent stage, accompanied by a sharp decrease or loss of organ function.
Hyalinosis — the final stage driven by the destruction of fibrous structures and increased vascular permeability.

Amyloidosis is distinguished separately as it involves the formation of an abnormal fibrillar protein and does not strictly follow this linear chain.

Which specific disorders belong to hereditary storage diseases (thesaurismoses)?

Hereditary storage diseases (thesaurismoses) include systemic lipidoses resulting from genetic enzyme deficiencies. This group comprises the following specific conditions:

Cerebroside lipidosis — Gaucher disease, characterized by the accumulation of abnormal lipid-carbohydrate complexes.
Sphingomyelin lipidosis — Niemann-Pick disease.
Ganglioside lipidosis — Tay-Sachs disease.
Generalized gangliosidosis — Landing disease.

In these pathologies, metabolic intermediates are not degraded but accumulate in cells of the liver, spleen, bone marrow, and central nervous system.

What are thesaurismoses?

These are storage diseases. They develop in hereditary dystrophies when metabolic products fail to be metabolized due to a genetic enzyme defect (enzymopathy) and are instead stored within tissues.

How does infiltration differ from aberrant synthesis?

Infiltration involves the accumulation of normal substances (derived extracellularly or unprocessed due to enzyme deficiency), whereas in aberrant synthesis, the cell produces abnormal compounds not normally found in the body (e.g., amyloid).

What does the term 'orthology' mean in the context of dystrophies?

This concept implies that in specific organs and tissues, due to their unique structure and function, a single morphogenetic mechanism of dystrophy predominates and is most typical for them.

Go deeper

Parenchymal protein dystrophies: granular, hyaline-droplet, hydropic
Stromal-vascular dysproteinoses and mechanisms of amyloid formation
Morphological features of myocardial and hepatic fatty change (steatosis)
Disturbances of carbohydrate metabolism using diabetes mellitus as a model
Differences between coagulative and liquefactive necrosis as outcomes of dystrophies